Report overview
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
This report aims to provide a comprehensive presentation of the global market for Dry Eye Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Eye Drugs. This report contains market size and forecasts of Dry Eye Drugs in global, including the following market information:
Global Dry Eye Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Dry Eye Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Dry Eye Drugs companies in 2022 (%)
The global Dry Eye Drugs market was valued at US$ 8827.4 million in 2022 and is projected to reach US$ 18890 million by 2029, at a CAGR of 11.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Dry Eye Drugs key players include Novartis AG, Valeant Pharmaceuticals, Allergan, Johnson & Johnson, Santen Pharma, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share about 40%, followed by Asia-Pacific, and Europe, both have a share about 40 percent.
In terms of product, Artificial Tears is the largest segment, with a share over 85%. And in terms of application, the largest application is Hospital, followed by Drug Stores, Online Pharmacies.
We surveyed the Dry Eye Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dry Eye Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dry Eye Drugs Market Segment Percentages, by Type, 2022 (%)
Artificial Tears
Anti-inflammatory Drugs
Other
Global Dry Eye Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dry Eye Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Drug Stores
Online Pharmacies
Global Dry Eye Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dry Eye Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dry Eye Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Dry Eye Drugs revenues share in global market, 2022 (%)
Key companies Dry Eye Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Dry Eye Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Novartis AG
Bausch Health
Santen Pharma
Takeda
Johnson & Johnson
United Laboratories
Senju Pharmaceutical
Jianfeng Group
Eusan GMBH
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dry Eye Drugs, market overview.
Chapter 2: Global Dry Eye Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Dry Eye Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dry Eye Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Dry Eye Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
